Palliative embolisation for advanced bone sarcomas.

Area of Science:

• Oncology
• Interventional Radiology
• Palliative Care

Background:

• Advanced bone sarcomas (recurrent, unresectable, metastatic) primarily require palliative management.
• The role of embolisation for pain relief in these patients has not been well-documented.

Purpose of the Study:

• To evaluate the palliative role of embolisation in providing pain relief for patients with advanced bone sarcomas.
• To assess the impact of embolisation on pain scores and analgesic requirements.

Main Methods:

• Retrospective study of 43 advanced bone sarcoma patients treated with palliative embolisation using N-2-butyl-cyanoacrylate.
• Patients received embolisation as end-stage treatment for severe local pain after primary therapies.
• Pain relief and analgesic use were evaluated, with a mean follow-up of 7 months.

Main Results:

• Angiography revealed increased pathological vascularisation in all sarcomas.
• 36 patients with hypervascular, pelvic, or shoulder girdle sarcomas experienced significant pain relief and >50% reduction in analgesic use.
• Seven patients with spinal/sacral lesions had moderate pain relief and 50% analgesic reduction. No recurrent pain was reported; complications were minor and resolved.

Conclusions:

• Embolisation is a safe and effective palliative treatment for advanced bone sarcomas.
• It provides optimal pain relief with minimal discomfort and manageable complications.
• This interventional technique can significantly improve the quality of life for patients with end-stage bone sarcomas.